2-147929492-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001616.5(ACVR2A):​c.*2218A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.301 in 152,284 control chromosomes in the GnomAD database, including 8,453 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.30 ( 8404 hom., cov: 31)
Exomes 𝑓: 0.51 ( 49 hom. )

Consequence

ACVR2A
NM_001616.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.66

Publications

14 publications found
Variant links:
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001616.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR2A
NM_001616.5
MANE Select
c.*2218A>T
3_prime_UTR
Exon 11 of 11NP_001607.1
ACVR2A
NM_001278579.2
c.*2218A>T
3_prime_UTR
Exon 12 of 12NP_001265508.1
ACVR2A
NM_001278580.2
c.*2218A>T
3_prime_UTR
Exon 11 of 11NP_001265509.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACVR2A
ENST00000241416.12
TSL:1 MANE Select
c.*2218A>T
3_prime_UTR
Exon 11 of 11ENSP00000241416.7
ACVR2A
ENST00000535787.5
TSL:2
c.*2218A>T
3_prime_UTR
Exon 11 of 11ENSP00000439988.1

Frequencies

GnomAD3 genomes
AF:
0.300
AC:
45575
AN:
151798
Hom.:
8394
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0876
Gnomad AMI
AF:
0.395
Gnomad AMR
AF:
0.339
Gnomad ASJ
AF:
0.229
Gnomad EAS
AF:
0.378
Gnomad SAS
AF:
0.468
Gnomad FIN
AF:
0.511
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.375
Gnomad OTH
AF:
0.270
GnomAD4 exome
AF:
0.514
AC:
189
AN:
368
Hom.:
49
Cov.:
0
AF XY:
0.541
AC XY:
120
AN XY:
222
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.517
AC:
187
AN:
362
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AF:
0.250
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.300
AC:
45603
AN:
151916
Hom.:
8404
Cov.:
31
AF XY:
0.312
AC XY:
23147
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.0874
AC:
3628
AN:
41528
American (AMR)
AF:
0.340
AC:
5163
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.229
AC:
796
AN:
3470
East Asian (EAS)
AF:
0.379
AC:
1961
AN:
5176
South Asian (SAS)
AF:
0.468
AC:
2256
AN:
4818
European-Finnish (FIN)
AF:
0.511
AC:
5379
AN:
10528
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.375
AC:
25433
AN:
67888
Other (OTH)
AF:
0.275
AC:
581
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1493
2985
4478
5970
7463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.330
Hom.:
1191
Bravo
AF:
0.272
Asia WGS
AF:
0.448
AC:
1541
AN:
3446

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.022
DANN
Benign
0.46
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13430086; hg19: chr2-148687061; API